<p>This study represents a merged international multi-cohort project of pooled biological and behavioral data from ten prospective cohorts of injection drug users (Grebely J, Morris MD, Rice TM, Bruneau J, Cox AL, Kim AY, et al., 2012, PMID: <a href="https://www.ncbi.nlm.nih.gov/pubmed/23203695">23203695</a>). Of the 10 cohorts, six provided data and samples for the genome wide association study (GWAS) entitled “Genetic Analysis of Opioid Addiction in People Who Inject Drugs”. The InC3 cohorts included in the GWAS were: i) Australian Trial in Acute Hepatitis C (ATAHC-I, Sydney); ii) Hepatitis C Incidence and Transmission Study in Prison (HITS-p) (Sydney); iii) Hepatitis C Incidence and Transmission Study in Community (HITS-c) (Sydney); iv) HepCo Study (Montreal); v) SuperMIX Study (combining the Networks II &#x26; MIX studies, Melbourne); and vi) the UFO Study (San Francisco).</p>

International Collaboration of Incident HIV and HCV in Injecting Cohorts    (InC3)

Hepatitis C study with SNP/CNV (Array) data on dbGaP (1,887 participants)